KLF4 also inhibits the tumor proliferation and metastasis of non-small cell lung cancer (NSCLC) through downregulating cyclin D1, upregulating p21, and inhibiting MSI2: an activator of the JAK/STAT3 signaling pathway that promotes metastasis [130]. This evidence concerns the gene MSI2 and non-small cell lung carcinoma.